Conditions: Major Depressive Disorder
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 155
Healthy volunteers: no

Brief summary:
To examine the safety and efficacy of long term administration of aripiprazole as an adjunctive therapy, co-administered with either a selective serotonin reuptake inhibitor (SSRI) or a selective-norepinephrine reuptake inhibitor (SNRI), in subjects with major depressive disorder.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: OPC-14597 (Aripiprazole)
Intervention descriptions: intervention 1: administered orally once daily, 3 to 15 mg daily, 52 weeks

Protocol document: